The current evidence-base for the psychological treatment of distressing voices indicates the need for further clinical development. The Maastricht approach (also known as Making Sense of Voices) is popular within sections of the Hearing Voices Movement, but its clinical effectiveness has not been systematically evaluated. The aim of the approach is to develop a better understanding of the role of the voice, in part through opening a dialogue between the voice hearer and the voice. The current study was a (N=15) case series adopting a concurrent multiple baseline design. The Maastricht approach was offered for up to 9-months. The main outcome, weekly voice-related distress ratings, was not statistically significant during intervention or follow-up, although the effect size was in the moderate range. The PSYRATS Hallucination scale was associated with a large effect size both at the end of treatment, and after a 3-month follow-up period, although again the effect did not reach statistical significance. The results suggest further evaluation of the approach is warranted. However, given the large variance in individual participant outcome, it may be that a better understanding of response profiles is required before conducting a definitive randomised controlled trial. 
Introduction
The prevalence of hallucinatory experience within the general population has been estimated at 6% (Linscott & van Os, 2013) . Within the psychiatric system, voice-hearing experiences are reported to have a lifetime prevalence of around 64 -80 % in people diagnosed with schizophrenia spectrum disorders (McCarthy-Jones et al., 2017) . Voice hearing is also associated with a range of other mental health problems, including bipolar disorder, depression, personality disorders, posttraumatic stress disorder (PTSD) and dissociative identity disorder, as well as with individuals without a history of mental health problems (Baumeister, Sedgwick, Howes & Peters, 2017 ).
The dominant perspective within which voices are understood remains the biomedical model, in which voice hearing is perceived as a symptom of an underlying illness, such as schizophrenia. Within this model, the content of the voices is considered of limited relevance, and the primary treatment strategy is to remove, or to reduce, the voice hearing experience via pharmaceutical intervention. However, since the conception of this approach in the 1950s, there has been negligible development in the effectiveness of anti-psychotic medication (Jones et al., 2006; Leucht et al., 2017) . There is also an increased awareness of the dangers associated with the long-term prophylactic use of these drugs including reduced cortical volume and a potential for dopamine supersensitivity (Murray et al., 2016) . Also, it is now clear that many people diagnosed with schizophrenia recover without the use of neuroleptic medication (Harrow, & Faull, 2014) . Furthermore, the effectiveness of neuroleptics has been shown to be reduced in individuals with a history of trauma (Hassan & De Luca, 2015) , a finding that is particularly relevant to voice hearing, which is associated with a high level of exposure to traumatic events (Varese et al. 2012 There has also been a recent increase in the awareness of the high prevalence of traumatic life events experienced by people who have been diagnosed with schizophrenia (e.g. Matheson, Shepherd, Pinchbeck, Laurens & Carr, 2013) . The prevalence of PTSD has been estimated to be approximately 13% within this group (Achim et al., 2011) . This comorbid presentation is associated with a poor prognosis and increased use of healthcare (Switzer et al., 1999 places on exploring the content, potential meaning and intentions of the voices (Corstens et al., 2014; Longden, 2017) .
The Maastricht approach is also referred to as 'Making Sense of Voices' (MsV; Romme & Escher, 2000) and Experience Focussed Counselling (Schnackenberg, Fleming & Martin, 2017; Schnackenberg, Fleming & Martin, 2018b; Schnackenberg, Walker, Fleming & Martin, 2018a) . The version adopted within the current study consists of three phases of work. First, an engagement phase and a discussion of basic coping strategies that may help with distressing voices. Second, an assessment phase occurs in which the voice content and characteristics are collaboratively explored using a form of psychological formulation known as 'the construct'. The third phase involves the development of a new voice-hearer led understanding of the voices, possibly in relation to life events. Subsequent work, based on the new understanding, is aimed at supporting the voice hearer to feel less threatened by the voice hearing experience and to adopt a less submissive position. The approach also includes 'Voice Dialoguing' techniques in which the voice hearer is encouraged to engage in an active dialogue with their voices. The aim is to resolve conflict and develop a new understanding of the meaning behind the voice content (Corstens, Longden & May, 2012) .
The MsV approach is highly regarded within the service user movement, and offers a new perspective for helping individuals come to terms with voice hearing experiences who may not have found the support they need within mainstream psychiatric services (Longden, Corstens & Dillon, 2013) . There are also indications that the MsV approach is applicable 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w  O  n  l  y   5 transdiagnostically (Schnackenberg et al., 2018a) and may be considered an approach that is sensitive to a trauma history (Schnackenberg et al., 2018b) . However, the current evidencebase for the MsV approach is limited to a small pilot randomised controlled trial (Schnackenberg et al., 2017) , assessment of specific elements of the approach (Corstens & Longden, 2013 ) and a collection of personal testimonies (Romme, Escher, Dillon, Corstens & Morris, 2009) . Given the widespread use of the MsV approach it is important that it receives further evaluation.
The current study aimed to evaluate outcomes of the MsV approach with a particular focus on using Voice Dialoguing techniques. The main outcome was voice-related distress.
However, a number of secondary outcomes were included in order to gather information on potential mechanisms that may be associated with the intervention and worthy of further investigation in future research. The case series involved a randomised period of baseline, a 9-month period of intervention and a 3-month follow-up. Although the MsV approach was not developed with a fixed number of sessions in mind, we offered a maximum of 20 sessions within 9-months so as to be able to make broad comparisons with the outcomes of other clinical trials in the field.
Method

Participants
To be considered for the case series, potential participants had to report currently distressing voices as determined by a rating of 2 or above on the 'Intensity of Distress' item on the 
Design
A concurrent multiple baseline design was used. Participants were randomly allocated to receive either a 4, 5, 6, 7 or 8-week wait duration (3 in each condition), prior to the intervention starting. Having a varied length of baseline allowed for the differentiation between the time effects during the baseline phase and the experimental effects during the intervention phase. The intervention consisted of a maximum of 20 individual sessions to be conducted within a 9-month period starting at the end of the waitlist. Assessments on the primary outcome (a measure of voice-related distress) were conducted on a weekly basis.
Secondary assessments were conducted on up to five occasions; prior to the waitlist period starting (baseline), at the end of wait list period (pre-treatment), at the end of the construct phase of intervention (post-construct), at the end of the intervention (post-treatment) and at a 3-month follow-up from the end of the intervention. The post-construct assessment was only conducted with the participants who progressed to this stage of the process and therefore this data was not included in the main statistical analyses.
The study was given NHS ethical approval by the South Central Berkshire B (15/SC/0013) and the protocol was registered (ISRCTN5437085).
The Making Sense of Voices Approach (Romme & Escher, 2000)
Assessment and construct:
After engagement, the first phase of the approach involves conducting the Maastricht Hearing Voices Interview. For many voice hearers, this forms part of the intervention as the The MsV intervention (comprising of the assessment, construct and intervention phases) was delivered individually by one of four mental health workers (two clinical psychologists and 
Outcome measures
Main Outcome
Hallucination Change Scale (HCS, Hoffmann et al., 2003) . The primary outcome, HCS, was based on weekly ratings of the distress associated with voice hearing and is hereafeter referred to as 'voice-related distress'. Each participant generated a narrative description of their voices for the one-week period prior to initiation of the first assessment, and rated the associated level of distress. This rating then became the baseline or '0' rating for the purpose of calibrating future ratings. The weekly voice-related distress ratings were scored in subsequent assessments by requesting the voice-hearer to generate a new narrative description of their voices.
Subsequent severity scores ranged from +10, corresponding to a maximum possible decrease in voice-related distress, to a score of -10, corresponding to a maximum possible increase in voice-related distress. Ratings corresponded to the average experience over the previous week, and were always rated with reference to the original zero calibration score. Data was collected on a weekly basis during the wait and intervention phase, and on a monthly basis during the 3-month follow-up phase.
Secondary Outcomes
Psychotic Symptoms Rating Scale for Auditory Hallucinations (PSYRATS (AH);
Haddock et al., 1999). 11 items completed on the basis of a clinical interview enabling Physical Health Questionnaire (PHQ9; Kroenke, Spitzer & Williams, 2001 ). A 9-item self-report measure of depression covering all nine of the DSM-IV criteria and based on assessment of the frequency over the previous two weeks.
Dissociative Experience Scale (DES; Bernstein & Putman, 1986) . A 28-item self-report measure of a wide variety of types of dissociation, including both problematic dissociative experiences and normal dissociative experiences (e.g. day-dreaming). Only the DES-Taxon 8-item subscale is reported in this study which measures a discontinuous, pathological class of dissociation.
Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; Tennant et al., 2006) . A 14-item self-report questionnaire which includes both hedonic and eudaimonic features rated on a five-point scale. A brief form of the original 26-item scale which was designed to measure self-judgement, self-kindness and self-criticism.
Statistical analysis
The primary endpoint was analysed using linear mixed models. The fixed effects ( ). The models also included random intercept for subject and used an ARMA(1,1) covariance structure for the repeated time within subject. These account for the between subject variation and within subject variation. Due to the small sample size the Kenwood Roger degrees of freedom adjustment was used. Random slopes were also investigated however these often lead to issues with the models or reduced fit and therefore were not included. An initial model was fitted to only test a linear time effect. After this a full model containing all predictors as described above was fitted and then the time within phase predictors were assessed and removed in a backwards stepwise fashion if they were not significant. If the main linear effect of time was not significant at this stage it was removed.
The random effects were included in all models. Cohen's d was derived as an effect size of the treatment and follow-up phases compared to baseline. The difference between phase of interest and the baseline (wait weeks) phase was taken from the relevant parameter estimates from the fixed part of the model. The denominator used was the square root (between subject variance + (within subject variance/average number of measurements per phase)). The All available data was used in the analyses and all missing data was assumed to be missing at random. The analyses using restricted maximum likelihood are robust when outcomes are missing at random. However, two participants stopped hearing voices during the intervention and therefore some assessments were not relevant (BAVQ-R and DAIMON) and were initially recorded as missing, sensitivity analyses were performed where these missing values were imputed as the 'best case' for these assessments (BAVQr Malevolence, BAVQr Omnipotence and DAIMON Voice addresses person were inputted as zero, BAVQr
Benevolence was inputed as 18 and DAIMON Person address Voice was inputted as 40). The statistical analyses were performed using SAS 9.4. 
Results
Fifteen participants were recruited (see Table 1 for baseline characteristics), with three participants randomised to each of the five wait durations. All participants were being prescribed anti-psychotic medication at the time of their initial screening assessment.
---------------- Table 1 here
Eleven participants remained fully engaged throughout the study and received between 18 and 20 individual sessions within the 9-month period allocated for the MsV intervention. Four participants disengaged from the intervention before the end of treatment, although one of these had received 15 sessions and remained engaged with the wider study and provided some follow-up data. Three participants did not complete the assessments for the secondary outcomes at post-treatment or follow-up. One of these received 5 sessions before they moved out of the NHS Trust within which the study was being conducted. Two participants stated that they did not find the approach beneficial and requested that they no longer be contacted after the point at which they withdrew from the intervention (5 sessions for one and 6 sessions for the other). Overall 28.13% of the weekly voice-related distress ratings were missing. There were no serious adverse events associated with the intervention for any of the participants during the study.
The individual weekly voice-related distress ratings of the 15 participants during the different phases of the study are shown in Figure 1 .
---------------- Figure 1 here 
----------------
The initial mixed regression analysis fitting time showed a statistically significant linear effect of time (parameter estimate 0.066, t=2.11, p=0.049). Once all predictors were entered, time within treatment phase and time within follow-up phase were not statistically significant and were removed from the model in a stepwise fashion. After these were removed, the linear effect of time was also not statistically significant (parameter estimate 0.058 t=1.51, p=0.14)
and was also removed from the model. Table 2 presents the final results from the linear mixed regression analysis of the weekly hallucination change scores. The intervention (MsV)
did not have a statistically significant effect on the weekly voice-related distress ratings, either during the intervention (as compared to baseline (wait weeks)) or follow-up phase (as compared to baseline (wait weeks)). However, the effect sizes were in the moderate range.
The individual profile plots and inspection of the conditional residuals from the model gave some indication that participants seemed to broadly fit into either a group who responded well to the approach or to a group who did not respond at all. Therefore, some caution needs to be taken in the interpretation of the results. The sensitivity analysis yielded similar conclusions for the final model. Figures 2a and 2b show the observed means and the predicted means from the analysis respectively.
---------------- Table 2 here Figure 2b here (currently a pdf)
Note that for figures 2a and 2b week1 is the first intervention session for a participant. Table 3 presents the post-treatment and follow-up data for all secondary outcomes. With the exception of the self-compassion scale and BAVQ-R omnipotence scale at follow-up, no outcomes were associated with a statistically significant difference from pre-treatment.
However, there were large effect sizes for PSYRATS both at the post-treatment and followup compared with pre-treatment, whilst the BAVQ-R malevolence and omnipotence scores indicated a moderate effect at post-treatment and a large effect at follow-up. It must be noted that for some endpoints the variability increased for post-treatment and follow-up timepoints compared to baseline and pre-treatment, this is particularly evident in the PSYRATS scores.
Note that the standardised effect size presented uses pre-treatment s.d as its denominator.
There were also no observed statistically significant differences between pre-treatment and Table 3 here
----------------
Discussion
The intervention was viable to deliver within a mainstream clinical NHS setting. Most of the participants maintained engagement throughout the full 9-month intervention phase which suggests acceptability from both voice hearers and staff. Given that directly engaging with a voice through dialogue may induce clinical concern within some mental health workers, it is important to note that there were no adverse events associated with the intervention.
Results based on the main outcome, the weekly voice-related distress ratings, indicated that the reduction in distress reported by voice hearers throughout the intervention or follow-up phase was not statistically significant. The small sample size will have limited the opportunity for statistical significance, and it is of note that the effect size of 0.38 at posttreatment and 0.56 at follow-up are indicative of the potential for the intervention to provide clinically meaningful change. In fact, these effect sizes are similar to those reported for individual CBT for voices (van der Gaag et al., 2014) . It is also of interest that the effect size for MsV was larger at follow-up than at post-treatment. Anecdotally, it was observed that several participants struggled to keep a meaningful frame of reference within the weekly change scores and this is likely to have reduced the reliability of this outcome.
With respect to the secondary outcome measures, there were large effect sizes on the PSYRATS Hallucination scale both at post-treatment and at follow-up, although again these did not reach statistical significance. Two of the outcome measures (self-compassion and BAVQ-R -omnipotence) did produce statistically significant differences at follow-up compared to pre-treatment. However, these results are to be treated with caution given the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The large effect sizes for the voice related outcome measures, and the trend towards an increased effect at follow-up suggests that the MsV approach warrants further investigation. In part this will be done via a qualitative analysis of interviews conducted with the participants of the current case series (in preparation). However, a future study will require a parallel control condition, in order to account for the variety of factors that are not specifically associated with the intervention, but that may have impacted on the outcomes of the current study.
Our outcome data indicated a wide variety of responses across the participants. This result is consistent with the anecdotal feedback from the mental health workers in this study who often commented on their experience of the participants varying in their engagement with the Voice Dialoguing component of the intervention. It may be that this 'ingredient' is an important part of this approach and that, prior to larger scale evaluation, efforts should be made to establish who is most likely to benefit. One aspect of voice hearing that is likely to be of interest in this respect is the extent to which the voice hearer dissociates whilst communicating with their voices, which may be linked to the extent to which the voice is experienced as a disconnected 'other' with whom a dialogue can be initiated (Moskowitz, Mosquera & Longden, 2017) . It is also worth noting that whilst the MsV approach is not limited to any diagnostic category, although the majority of the current sample were diagnosed with a psychotic disorder. This may have had an impact on our outcomes through the impact of long-term use of neuroleptics (Murray et al., 2016) . Psychological Medicine, 44, [3007] [3008] [3009] [3010] [3011] [3012] [3013] [3014] [3015] [3016] Hayward, M., Berry, K., McCarthy-Jones, S., Strauss, C. and Thomas, N. (2013) .
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